Evidence map›Paper›PMID 37845605›Full record

ArticleBMC infectious diseases2023

A case of Vagococcus fluvialis isolated from the bile of a patient with calculous cholecystitis.

Dan Zhang, Xiaosu Wang, Jingdan Yu, Zheng Dai, Qichao Li, Litao Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Avian Infective Endocarditis Associated withAnimals : an open access journal from MDPI · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dan ZhangDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China.
Xiaosu WangDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China.
Jingdan YuDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China.
Zheng DaiDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China.
Qichao LiDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China.
Litao ZhangDepartment of Clinical Laboratory, Wuhan Asia General Hospital, Wuhan Asia General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province, 430056, People's Republic of China. dandanzhangnihao@126.com.
Wuhan General Hospital of Guangzhou · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic cholecystitis, characterized by persistent inflammation of the gallbladder, predominantly stems from the prolonged presence of gallstones. Calculous cholecystitis has demonstrated a consistent escalation in its incidence over time.Gallbladder stones have been recognized as a predisposing factor for the development of biliary tract infections.Concomitantly, there have been substantial shifts in the distribution and resistance profiles of pathogenic microorganisms responsible for biliary tract infections. The timely acquisition of bile samples for pathogen analysis is of paramount importance, given its critical role in guiding judicious clinical pharmacotherapy and enhancing patient prognosis. CASE PRESENTATION: We present a case involving a 66-year-old female patient who had previously undergone subtotal gastrectomy due to diffuse large B-cell lymphoma. The patient was admitted to our institution with complaints of abdominal pain. Subsequent diagnostic evaluation revealed concurrent choledocholithiasis and cholecystolithiasis. The patient underwent surgical cholecystectomy as the therapeutic approach. Histopathological examination of the excised gallbladder disclosed characteristic features indicative of chronic cholecystitis. Subsequent laboratory analysis of the patient's bile specimen yielded Gram-positive cocci, subsequently identified through biochemical assays, mass spectrometry, and 16 S rRNA analysis as Vagococcus fluvialis. Further in vitro antimicrobial susceptibility testing using disk diffusion and microfluidic dilution showed that this strain exhibited inhibition zone diameters ranging from 12.0 to 32.0 mm in response to 26 antibiotics, including ampicillin, cefazolin, cefuroxime, cefotaxime, ceftriaxone, cefepime, ampicillin/sulbactam, piperacillin, ciprofloxacin, cefoperazone/sulbactam, imipenem, meropenem, piperacillin/tazobarb, penicillin, erythromycin, chloramphenicol, vancomycin, methotrexate/sulfamethoxazole, teicoplanin, linezolid, tigecycline, cefoxitin, ceftazidime, levofloxacin, minocycline and tobramycin. However, the inhibition zone diameters were 6.0 mm for amikacin, oxacillin, clindamycin, and tetracycline. The patient received ceftazidime anti-infective therapy both preoperatively and within 24 h postoperatively and was discharged successfully one week after surgery.

conclusionIn this study, we present the inaugural isolation and identification of Vagococcus fluvialis from bile specimens of patients afflicted with calculous cholecystitis. This novel finding lays a substantial experimental groundwork for guiding clinically rational antimicrobial therapy and advancing the exploration of relevant pathogenic mechanisms pertaining to Vagococcus fluvialis infections.

Indexed as

Anti-Infective AgentsCholecystitisGram-Positive CocciAgedAmpicillinAnti-Bacterial AgentsBileCeftazidimeDrug Resistance, BacterialEnterococcaceaeFemaleHumansMicrobial Sensitivity TestsPiperacillinSulbactamAmpicillinAnti-Bacterial AgentsAnti-Infective AgentsCeftazidimePiperacillinSulbactamBacterial identificationChronic cholecystitisGallbladder stonesVagococcus fluvialis

Identifiers

PMID37845605
PMCPMC10578025
OpenAlexW4387672497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.